Skip to content
MedsAcross

Brand family

Phyrago

Dasatinib · Cycle Pharmaceuticals
United States
Presentations
6
Markets
1

Phyrago is a brand of Dasatinib marketed by Cycle Pharmaceuticals, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Dasatinib
Brand owner
Cycle Pharmaceuticals
Registered in
United States
Strengths and forms
100 mg tablet, 140 mg tablet, 20 mg tablet, 50 mg tablet, 70 mg tablet, 80 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Phyrago 100 mg tabletOralCycle PharmaceuticalsUS FDAAvailable on request
Phyrago 140 mg tabletOralCycle PharmaceuticalsUS FDAAvailable on request
Phyrago 20 mg tabletOralCycle PharmaceuticalsUS FDAAvailable on request
Phyrago 50 mg tabletOralCycle PharmaceuticalsUS FDAAvailable on request
Phyrago 70 mg tabletOralCycle PharmaceuticalsUS FDAAvailable on request
Phyrago 80 mg tabletOralCycle PharmaceuticalsUS FDAAvailable on request

Equivalent brands

Other brands of Dasatinib.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Phyrago

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.